IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
+8.94%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
-$68K
(-0.03%)
Cap. Flow
+$17.5M
Cap. Flow
% of AUM
7.25%
Top 10 Holdings %
Top 10 Hldgs %
40.16%
Holding
106
New
29
Increased
10
Reduced
19
Closed
6
Top Buys
| 1 |
Merck
MRK
|
$10.6M |
| 2 |
BridgeBio Pharma
BBIO
|
$9.86M |
| 3 |
Insmed
INSM
|
$8.27M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$7.32M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$6.6M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$17.5M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$10.2M |
| 3 |
Biohaven
BHVN
|
$5.94M |
| 4 |
Celldex Therapeutics
CLDX
|
$5.81M |
| 5 |
89bio
ETNB
|
$5.78M |
Sector Composition
| 1 | Healthcare | 97.84% |
